Peripheral Arterial Tonometry for Risk Stratification in Men With Coronary Artery Disease

被引:28
作者
Heffernan, Kevin S. [1 ]
Karas, Richard H. [1 ]
Patvardhan, Eshan A. [1 ]
Jafri, Haseeb [1 ]
Kuvin, Jeffrey T. [1 ]
机构
[1] Tufts Med Ctr, Mol Cardiol Res Inst, Dept Med, Div Cardiol,Vasc Funct Study Grp, Boston, MA 02111 USA
关键词
C-REACTIVE PROTEIN; MIDDLE-AGED MEN; REVERSIBLE ENDOTHELIAL DYSFUNCTION; HIGH-DENSITY-LIPOPROTEIN; PHOSPHOLIPASE A(2); NITRIC-OXIDE; CARDIOVASCULAR EVENTS; ATHEROSCLEROSIS RISK; BRACHIAL-ARTERY; HEART-DISEASE;
D O I
10.1002/clc.20705
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Coronary artery disease (CAD) risk is not fully revealed by traditional risk factors. Identification of a simple, noninvasive tool that allows for detection of high-risk CAD patients and can be applied in large populations and clinical settings would prove valuable. Hypothesis: We sought to test the hypothesis that peripheral arterial tonometry (PAT) would be associated with residual risk in men with CAD. Methods: In this study, finger PAT was used to measure pulse wave amplitude (PWA) during reactive hyperemia (RH) and taken as a measure of microvascular endothelial function in 42 men with stable CAD and well controlled tow-density lipoprotein cholesterol (LDL-C) levels. Plasma levels of high-sensitivity C-reactive protein (hs-CRP) and lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) were measured and used to reclassify men into high-risk (elevated hs-CRP and Lp-PLA(2)), moderate-risk (either elevated hs-CRP or Lp-PLA(2)), or low-risk (low hs-CRP and Lp-PLA(2)) groups. Results: PWA-RH was significantly lower in the high-risk group (1-3 +/- 0.04) compared to the moderate-risk (1.6 +/- 0.07, P < 0.05) and low-risk (2.0 +/- 0.1, P < 0.05) groups. According to binary logistic regression, PWA-RH was a significant predictor of high-risk status among men with CAD (P < 0.05). Conclusion: Measurement of peripheral microvascular endothelial function with PAT may be able to distinguish high-risk men from moderate- and low-risk men with stable CAD and well-controlled LDL-C levels and thus aid in residual risk stratification in this at risk cohort.
引用
收藏
页码:94 / 98
页数:5
相关论文
共 37 条
[1]   Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes [J].
Aversa, A. ;
Vitale, C. ;
Volterrani, M. ;
Fabbri, A. ;
Spera, G. ;
Fini, M. ;
Rosano, G. M. C. .
DIABETIC MEDICINE, 2008, 25 (01) :37-44
[2]   Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [J].
Ballantyne, CM ;
Hoogeveen, RC ;
Bang, H ;
Coresh, P ;
Folsom, AR ;
Chambless, LE ;
Myerson, M ;
Wu, KK ;
Sharrett, AR ;
Boerwinkle, E .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (21) :2479-2484
[3]   Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [J].
Ballantyne, CM ;
Hoogeveen, RC ;
Bang, H ;
Coresh, J ;
Folsom, AR ;
Heiss, G ;
Sharrett, AR .
CIRCULATION, 2004, 109 (07) :837-842
[4]   Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein [J].
Bisoendial, RJ ;
Hovingh, GK ;
Levels, JHM ;
Lerch, PG ;
Andresen, I ;
Hayden, MR ;
Kastelein, JJP ;
Stroes, ESG .
CIRCULATION, 2003, 107 (23) :2944-2948
[5]   Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia [J].
Bonetti, PO ;
Pumper, GM ;
Higano, ST ;
Holmes, DR ;
Kuvin, JT ;
Lerman, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (11) :2137-2141
[6]   Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease [J].
Bonetti, PO ;
Barsness, GW ;
Keelan, PC ;
Schnell, TI ;
Pumper, GM ;
Kuvin, JT ;
Schnall, RP ;
Holmes, DR ;
Higano, ST ;
Lerman, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) :1761-1768
[7]   Inflammation and endothelial function - Direct vascular effects of human C-reactive protein on nitric oxide bioavailability [J].
Clapp, BR ;
Hirschfield, GM ;
Storry, C ;
Gallimore, JR ;
Stidwill, RP ;
Singer, M ;
Deanfield, JE ;
MacAllister, RJ ;
Pepys, MB ;
Vallance, P ;
Hingorani, AD .
CIRCULATION, 2005, 111 (12) :1530-1536
[8]   Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker [J].
Corson, Marshall A. ;
Jones, Peter H. ;
Davidson, Michael H. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (12A) :41F-50F
[9]   Primary and subsequent coronary risk appraisal: New results from The Framingham Study [J].
D'Agostino, RB ;
Russell, MW ;
Huse, DM ;
Ellison, RC ;
Silbershatz, H ;
Wilson, PWF ;
Hartz, SC .
AMERICAN HEART JOURNAL, 2000, 139 (02) :272-281
[10]   Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines [J].
Davidson, Michael H. ;
Corson, Marshall A. ;
Alberts, Mark J. ;
Anderson, Jeffrey L. ;
Gorelick, Philip B. ;
Jones, Peter H. ;
Lerman, Amir ;
McConnell, Joseph P. ;
Weintraub, Howard S. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (12A) :51F-57F